Does Biotin Affect the Liver or Liver Function Tests?

Biotin, even at high supplement doses, does not appear to directly damage a healthy liver. The real concern is different and frequently misunderstood: biotin can dramatically distort the results of many common blood tests, including some used to evaluate liver health and screen for hepatitis. This happens not because the vitamin is harming your liver, but because many laboratory immunoassays rely on the same biotin-streptavidin chemistry that gets thrown off when your blood contains extra biotin from supplements. The distinction between actual liver harm and misleading lab results matters enormously, because confusing the two can lead to unnecessary panic, additional testing, or even misdiagnosis.

Biotin’s Normal Role in Liver Metabolism

Your liver is one of the organs most involved in biotin’s everyday work. Biotin is a water-soluble B vitamin (B7) that acts as a helper molecule for five enzymes in the human body, all of which carry out carboxylation reactions essential for processing fats, sugars, and amino acids.¹ Several of these enzymes are heavily active in liver cells. Pyruvate carboxylase, for instance, is critical for making new glucose, while acetyl-CoA carboxylase helps regulate fat production. Without biotin, these metabolic pathways stall.²

The liver also plays a role in how the body handles biotin itself. The vitamin is absorbed in the gut and transported into liver cells through specific transporter proteins. The enzyme biotinidase, which recycles biotin from used-up enzymes so the body can reuse it, is produced largely in the liver.³ This close relationship between the liver and biotin metabolism runs both directions, and it becomes clinically relevant when someone has liver disease, as we’ll see later.

Does Taking Biotin Supplements Damage the Liver?

There is no strong evidence that biotin supplementation harms liver tissue in otherwise healthy people. The most informative study on this topic looked at mice given biotin-supplemented diets and examined what happened to their livers. The supplemented group did show some changes in liver cell structure under the microscope. However, when researchers checked the standard blood markers of liver damage, almost all of them were normal. Alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma-glutamyltransferase (GGT), total and direct bilirubin, albumin, and urea showed no differences between supplemented and non-supplemented groups. The one exception was aspartate aminotransferase (AST), which was statistically higher in the biotin group, though the values still fell within the normal reference range.⁴

That finding is worth understanding carefully. A value that is “statistically higher” but still within the normal range is not the same as a value that signals liver injury. The researchers specifically concluded that while biotin changed the liver’s microscopic appearance, it did not produce changes in liver toxicity markers. This is an animal study, so extrapolating directly to humans requires caution, but it is the most direct experimental evidence available on the question of whether biotin supplementation harms liver tissue, and the answer leans firmly toward no.

At very high concentrations, biotin does influence gene activity in liver cells. It can increase the activity of glucokinase, an enzyme that helps the liver process blood sugar, while suppressing the enzyme responsible for gluconeogenesis (making new glucose from scratch).⁵ These metabolic shifts are not the same as liver damage. They represent the vitamin doing its metabolic job more aggressively, and they have actually been explored as a potential therapeutic approach for blood sugar regulation.

The Real Problem With Biotin and Lab Tests

Where biotin creates genuine clinical trouble is not inside the liver but inside the laboratory. Many modern blood tests, called immunoassays, are built around a molecular trick: they use the extraordinarily strong bond between biotin and a protein called streptavidin to capture and measure whatever substance the test is looking for. When you take biotin supplements, the extra biotin floating in your blood competes with the biotin built into the test kit, and this throws off the measurement.⁶

The direction of the error depends on the test’s design. In so-called “sandwich” assays, which are used for larger molecules, biotin interference tends to push results falsely low. In “competitive” assays, used for smaller molecules like hormones, the results tend to read falsely high. The practical result is that you can get lab results that look alarming or reassuring when neither is true. A test might suggest your thyroid is overactive when it’s fine, or indicate your troponin (a heart attack marker) is normal when it’s not.

One study systematically tested the effect of biotin interference across 16 different Roche immunoassays covering cortisol, thyroid hormones, insulin, cardiac markers, HIV, and others. All but two of them showed significant interference from high biotin levels.⁷ The scope of the problem is broad enough that the FDA issued a safety communication warning about it, and case reports have documented real patients receiving wrong diagnoses because their biotin supplements were distorting their bloodwork.⁸

Hepatitis Screening and Liver-Related Tests Are Especially Vulnerable

If you’re specifically concerned about liver function tests, the interference problem hits particularly close to home with hepatitis serology. One study spiked blood samples with biotin at levels that would be seen after taking high-dose supplements and then ran standard hepatitis tests. The results were striking: in samples that were truly negative for hepatitis A antibodies, biotin produced 100% false-positive results at both biotin concentrations tested. For hepatitis B core antibodies, the false-positive rate was 90% at the higher biotin level. And for IgM anti-HBc (a marker used to diagnose acute hepatitis B), the false-negative rate reached 87.5% at the higher concentration.⁹

A separate study found similarly alarming numbers. After simulating a 100 mg biotin dose (a level used therapeutically for multiple sclerosis), about 40% of cases showed a false-negative result for hepatitis B surface antibodies, the marker used to confirm immunity after vaccination. Roughly half of anti-HIV results and two-thirds of anti-hepatitis C results read as false negatives at peak biotin levels.¹⁰ Think about what this means practically: a person with hepatitis C could receive a reassuring “negative” result simply because they were taking biotin, or a healthy person could be told they have hepatitis A when they don’t.

Standard liver chemistry panels, the ones that measure enzymes like ALT, AST, and bilirubin directly, are generally less vulnerable to this kind of interference because they use different analytical methods. But any liver-related test that runs on a streptavidin-biotin immunoassay platform is potentially at risk. And because many hospitals run dozens of different tests on the same automated analyzer, the platform’s reliance on biotin-streptavidin chemistry becomes a systemic vulnerability.

How Much Biotin Causes Trouble?

The adequate daily intake of biotin for adults is only about 30 micrograms. Many “hair, skin, and nails” supplements contain 5,000 to 10,000 micrograms (5 to 10 milligrams), which is already over 100 times the recommended intake. The interference risk scales with dose, so the higher the supplement dose, the more likely your tests will be affected.

The most extreme biotin doses are used therapeutically. Patients with multiple sclerosis participating in clinical trials have taken 300 mg of biotin per day, which is 10,000 times the adequate intake. At those levels, the interference is severe and essentially guaranteed for any test using streptavidin-biotin chemistry.¹¹ But even the 5 to 10 mg range found in common over-the-counter supplements can produce clinically meaningful distortions in sensitive assays, particularly if blood is drawn soon after taking the supplement.

Because biotin is water-soluble, the body clears it relatively quickly through the kidneys. Blood levels peak within a few hours of taking a dose and decline over the following day. This is why the standard advice is to stop biotin supplements at least 24 hours before a blood draw, and longer (up to 72 hours) if you’re taking very high doses. That washout period allows blood levels to drop low enough that the interference becomes negligible for most assays.

What Laboratories Are Doing About It

Lab scientists are well aware of this problem and have developed workarounds. The most practical approach involves using streptavidin-coated magnetic particles to soak up the excess biotin in a blood sample before running the actual test. Researchers have demonstrated that this pre-treatment can restore normal results even in samples from patients taking 300 mg of biotin daily.¹¹ Another approach involves pre-mixing the assay’s capturing molecules with streptavidin beads before adding the patient sample, effectively neutralizing biotin interference for certain test types.¹²

Not all labs have adopted these techniques, and they add time and cost to testing. In many clinical settings, the primary defense is still a simple one: asking patients whether they take biotin-containing supplements. The problem is that biotin shows up in all sorts of products. It’s in prenatal vitamins, B-complex vitamins, multivitamins, and standalone hair and nail supplements, and patients often don’t realize they’re taking it. If nobody asks, the interference goes unnoticed until someone gets test results that don’t match the clinical picture, at which point a clinician may or may not think to check for biotin as the culprit.⁸

When Liver Disease Affects Biotin Status

The relationship between biotin and the liver goes both ways. Just as biotin affects certain lab tests, liver disease itself can disrupt biotin metabolism. The liver produces biotinidase, the enzyme that recycles biotin for reuse. When the liver is severely damaged, biotinidase production drops, and this has measurable consequences.

In one study of patients with various forms of liver disease, serum biotinidase activity was roughly half of what it was in healthy controls. The most severely affected patients were those with decompensated liver cirrhosis and liver cancer, whose biotinidase levels were significantly lower than patients with acute or chronic viral hepatitis or compensated cirrhosis. These patients also had lower blood biotin levels and were excreting more biotin in their urine, suggesting their bodies could not hold onto the vitamin properly. When some of these patients received biotin supplements, their levels of certain abnormal metabolites dropped, suggesting that a functional biotin deficiency had been contributing to their metabolic problems.¹³

This pattern has been confirmed in other populations. Children with cirrhosis and Wilson disease (a genetic condition causing copper accumulation in the liver) also show significantly reduced biotinidase activity compared to healthy children.¹⁴ And in patients with glycogen storage diseases, where the liver is progressively damaged by abnormal glycogen accumulation, biotinidase activity drops in parallel with the severity of fibrosis and cirrhosis.¹⁵

The implication is that people with advanced liver disease may actually need more biotin than healthy individuals, because their damaged livers can’t recycle it efficiently. This is an area where supplementation might genuinely help rather than just being cosmetic, but it’s also an area where the evidence is thin and mostly observational. No large randomized trials have tested whether biotin supplementation improves outcomes in liver disease patients.

How Certain Medications Fit In

Some medications can reduce biotin-dependent enzyme activity in the liver, creating a secondary deficiency even when dietary biotin intake is normal. The anticonvulsant carbamazepine is the best-studied example. In animal research, chronic carbamazepine administration significantly reduced the levels and activity of multiple biotin-dependent carboxylases in the liver, including pyruvate carboxylase and acetyl-CoA carboxylase.¹⁶ This partly explains the metabolic side effects sometimes seen in patients on long-term anticonvulsant therapy, including changes in organic acid profiles that resemble biotin deficiency.

For someone taking both carbamazepine and biotin supplements, the picture gets complicated. The drug may be depleting the functional benefit of biotin in the liver while the supplement floods the blood with excess free biotin that interferes with lab tests. The result could be a person whose liver enzymes are genuinely affected by drug-induced metabolic changes, but whose lab results are also being distorted by supplement interference, making it nearly impossible to interpret bloodwork correctly without knowing about both factors.

Animal Studies on Biotin Deficiency and Fatty Liver

Much of what we know about severe biotin deficiency and liver damage comes from animal research, particularly in poultry. Chicks raised on biotin-deficient diets develop a condition called fatty liver and kidney syndrome (FLKS), where fat accumulates abnormally in the liver and kidneys. In one study, mortality from FLKS reached 52% within 28 days on a diet low in biotin, fat, and protein, but adding back any of those three nutrients reduced or eliminated the deaths.¹⁷ Ultrastructural examination of the affected chick livers showed that the severity of the fatty changes correlated with the degree of biotin deficiency in liver tissue.¹⁸

These animal findings are interesting but not directly transferable to humans. True biotin deficiency severe enough to cause fatty liver in people is extremely rare, because biotin is widely available in foods like eggs, nuts, seeds, and organ meats, and gut bacteria also produce some. The relevance of these studies is mainly as a reminder that biotin is genuinely important for liver fat metabolism, and that the connection between biotin status and liver health is real at the biological level, even if supplement users are at no risk of deficiency.

Practical Steps if You Take Biotin

If you take any supplement containing biotin and need blood work done, a few simple steps can prevent the whole interference problem:

Check your labels: Biotin hides in many supplements. Any multivitamin, B-complex, prenatal vitamin, or beauty supplement may contain it, sometimes in high doses.
Stop early enough: For doses up to about 5 mg, stopping 24 hours before a blood draw is generally sufficient. For higher therapeutic doses (100 mg or more), stopping 48 to 72 hours in advance is safer.
Tell your doctor: If you’ve already had blood drawn while taking biotin and the results seem inconsistent with how you feel, mention the supplement. A lab can often rerun the tests using a biotin-depletion step or a different assay platform.
Know which tests are vulnerable: Thyroid panels, cardiac troponin, hormone levels, and hepatitis serology are among the most commonly affected. Basic metabolic panels and standard liver enzyme tests (ALT, AST) measured by enzymatic methods are generally safe.

The fundamental irony of biotin and liver function tests is that the vitamin itself appears to be benign to liver tissue, but its presence in your bloodstream can make it look like something is wrong with your liver on paper. For anyone scrolling supplement reviews wondering if their biotin pill is hurting their liver, the answer is almost certainly no. But if your doctor tells you your hepatitis screening came back positive and the only thing that changed recently was a new hair supplement, biotin interference should be the first thing anyone investigates.